Co-Diagnostics CODX
$ 1.01
-4.39%
Quarterly report 2024-Q3
added 11-07-2024
Co-Diagnostics Balance Sheet 2011-2024 | CODX
Annual Balance Sheet Co-Diagnostics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-11.9 M | -22.6 M | - | -43 M | -893 K | 958 K | -3.53 M | 283 K | 978 K | - | - | - | - |
Long Term Debt |
2.15 M | 50.7 K | - | - | - | - | - | 445 K | 524 K | - | - | - | - |
Long Term Debt Current |
838 K | 297 K | - | - | - | 1.91 M | - | - | - | - | - | - | - |
Total Non Current Liabilities |
3.56 M | 4.69 M | 13 M | 30 K | 150 K | 260 K | 184 K | 445 K | 524 K | - | - | - | - |
Total Current Liabilities |
5.75 M | 3.87 M | 12.6 M | 4.51 M | 328 K | 2.35 M | 628 K | - | - | - | - | - | - |
Total Liabilities |
9.31 M | 8.57 M | 25.6 M | 4.54 M | 478 K | 2.61 M | 812 K | 4.29 M | 1.52 M | - | - | - | - |
Deferred Revenue |
362 K | - | 150 K | 305 K | 1.32 K | - | 10.8 K | - | - | - | - | - | - |
Retained Earnings |
4.6 M | 39.9 M | 54.2 M | 17.5 M | -25 M | -18.7 M | -12.4 M | -5.46 M | -3.53 M | - | - | - | - |
Total Assets |
95.3 M | 123 M | 160 M | 71.2 M | 2.22 M | 1.55 M | 4.66 M | 1.3 M | 371 K | - | - | - | - |
Cash and Cash Equivalents |
14.9 M | 23 M | 88.6 M | 43 M | 893 K | 950 K | 3.53 M | 999 K | - | - | - | - | - |
Book Value |
86 M | 115 M | 134 M | 66.7 M | 1.74 M | -1.06 M | 3.85 M | -2.99 M | -1.15 M | - | - | - | - |
Total Shareholders Equity |
86 M | 115 M | 134 M | 66.7 M | 1.74 M | -1.06 M | 3.85 M | -2.99 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Co-Diagnostics
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.47 M | 1.7 M | 2.15 M | 2.25 M | 2.46 M | 658 K | 50.7 K | 126 K | 201 K | 276 K | - | - | - | - | - | - | - | - | - | - | - | - | 1.91 M | - | - | - | 278 K | 41.6 K | 41.6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
2.8 M | 3 M | 3.56 M | 4.09 M | 4.25 M | 2.76 M | 4.69 M | 6.88 M | 9.65 M | 10.4 M | 13 M | 1.08 M | 795 K | 555 K | 478 K | 30 K | 30 K | 30 K | 150 K | 170 K | 200 K | 150 K | 260 K | 260 K | 260 K | 260 K | 184 K | 664 K | 544 K | 544 K | 445 K | 445 K | 445 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
8.6 M | 8.3 M | 9.31 M | 9.19 M | 9.37 M | 6.37 M | 8.57 M | 12.9 M | 16.4 M | 23.4 M | 25.6 M | 5.2 M | 5.52 M | 4.86 M | 4.54 M | 4.54 M | 4.54 M | 4.54 M | 478 K | 478 K | 478 K | 478 K | 2.61 M | 2.61 M | 2.61 M | 2.61 M | 812 K | 812 K | 812 K | 812 K | 4.29 M | 4.29 M | 4.29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
60.5 K | 221 K | 362 K | 349 K | 258 K | 18.1 K | - | - | - | - | 150 K | 190 K | 163 K | 159 K | 305 K | 305 K | - | 305 K | 1.32 K | - | - | - | - | 39.2 K | 39.2 K | 39.2 K | 10.8 K | 10.8 K | 10.8 K | 10.8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-22 M | -12.3 M | 4.6 M | 19.3 M | 25.3 M | 34.2 M | 39.9 M | 61.8 M | 63.2 M | 65.9 M | 54.2 M | 46.7 M | 35.2 M | 25.4 M | 17.5 M | 17.5 M | 17.5 M | 17.5 M | -25 M | -25 M | -25 M | -25 M | -18.7 M | -18.7 M | -18.7 M | -18.7 M | -12.4 M | -12.4 M | -12.4 M | -12.4 M | -5.46 M | -5.46 M | -5.46 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
72.4 M | 80.7 M | 95.3 M | 109 M | 113 M | 117 M | 123 M | 148 M | 161 M | 171 M | 160 M | 105 M | 92.8 M | 81.1 M | 71.2 M | 71.2 M | 71.2 M | 71.2 M | 2.22 M | 2.22 M | 2.22 M | 2.22 M | 1.55 M | 1.55 M | 1.55 M | 1.55 M | 4.66 M | 4.66 M | 4.66 M | 4.66 M | 1.3 M | 1.3 M | 1.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
10.8 M | 13.9 M | 14.9 M | 10.2 M | 13.8 M | 6.36 M | 23 M | 81.5 M | 86 M | 97.4 M | 88.6 M | 82.7 M | 70.3 M | 57.8 M | 43 M | 43 M | 43 M | 43 M | 893 K | 893 K | 893 K | 893 K | 950 K | 950 K | 950 K | 950 K | 3.53 M | 3.53 M | 3.53 M | 3.53 M | 999 K | 999 K | 999 K | - | 33.8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
63.8 M | 72.4 M | 86 M | 99.5 M | 103 M | 111 M | 115 M | 135 M | 144 M | 148 M | 134 M | 100 M | 87.3 M | 76.3 M | 66.7 M | 66.7 M | 66.7 M | 66.7 M | 1.74 M | 1.74 M | 1.74 M | 1.74 M | -1.06 M | -1.06 M | -1.06 M | -1.06 M | 3.85 M | 3.85 M | 3.85 M | 3.85 M | -2.99 M | -2.99 M | -2.99 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
63.8 M | 72.4 M | 86 M | 99.5 M | 103 M | 111 M | 115 M | 135 M | 144 M | 148 M | 134 M | 100 M | 87.3 M | 76.3 M | 66.7 M | 66.7 M | 66.7 M | 66.7 M | 1.74 M | 1.74 M | 1.74 M | 1.74 M | -1.06 M | -1.06 M | -1.06 M | -1.06 M | 3.85 M | 3.85 M | 3.85 M | 3.85 M | -2.99 M | -2.99 M | -2.99 M | - | -1.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency